The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Quazepam: Hypnotic Efficacy and Side Effects
Abstract
Quazepam is a benzodiazepine hypnotic that can be useful in the adjunctive pharmacologic treatment of insomnia. It is slowly eliminated due to the long elimination half‐lives of the parent compound and its two active metabolites, 2‐oxoqua‐zepam and N‐desalkyl‐2‐oxoquazepam. This drug is recommended in doses of 15 mg for adults and 7.5 mg for geriatric patients. Sleep laboratory studies and clinical trials have shown that the 15 mg dose is quite efficacious for inducing and maintaining sleep not only with initial and short‐term use but also with continued use. The 7.5 mg dose which has been studied less extensively has also been shown to be effective for inducing and maintaining sleep. There is considerable evidence of carryover effectiveness both during drug administration and after withdrawal. Thus, rebound phenomena are not observed during administration (early morning insomnia and daytime anxiety) and after withdrawal (rebound insomnia). Furthermore, certain behavioral side effects that have occurred with certain benzodiazepines (triazolam) have not been reported with quazepam. The only notable side effect seen with quazepam is a variable degree of daytime sedation, which can be minimized by intermittent use of the 15 mg dose when necessary and use of the 7.5 mg dose in the elderly. In comparison to triazolam and temazepam, quazepam is more effective with short‐term use, and with continued use it maintains its efficacy in contrast to both of these drugs which show rapid development of tolerance. Most important, quazepam lacks the frequent and severe side effects increasingly reported with triazolam use or following its withdrawal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Some preliminary findings on physical complaints from a prospective study of 1,064,004 men and women
Hammond, E. C. (1964) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.54.1.11 · Cited by 401
Rebound Insomnia and Rebound Anxiety: A Review
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (2008) · Pharmacology · doi:10.1159/000137794 · Cited by 198
Self-citationKales, A., Caldwell, A. B., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (1983) · Psychosomatic Medicine · doi:10.1097/00006842-198308000-00008 · Cited by 170
Self-citationEarly Morning Insomnia with Rapidly Eliminated Benzodiazepines
Kales, A., Soldatos, C. R., Bixler, E. O., & Kales, J. D. (1983) · Science · doi:10.1126/science.6131538 · Cited by 138
Self-citationAnxiety caused by a short-life hypnotic.
Morgan, K., & Oswald, I. (1982) · BMJ · doi:10.1136/bmj.284.6320.942 · Cited by 137
MITLER, M. M., SEIDEL, W. F., DEN HOED, J. V., GREENBLATT, D. J., & DEMENT, W. C. (1984) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198402000-00002 · Cited by 98
Nitrazepam: lastingly effective but trouble on withdrawal.
Adam, K., Adamson, L., Brezinova, V, & Hunter, W. M. (1976) · BMJ · doi:10.1136/bmj.1.6025.1558 · Cited by 90
Chronic Hypnotic-Drug Use: Ineffectiveness, Drug-Withdrawal Insomnia, and Dependence
Kales, A. (1974) · JAMA · doi:10.1001/jama.1974.03230180011004 · Cited by 88
Self-citationComparison of short and long half-life benzodiazepine hypnotics: Triazolam and quazepam
Kales, A., Bixler, E. O., Vela-Bueno, A., Soldatos, C. R., Nikiaus, D. E., & Manfredi, R. L. (1986) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1986.194 · Cited by 66
Self-citationQuazepam and flurazepam: Long-term use and extended withdrawal
Kales, A., Bixler, E. O., Soldatos, C. R., Vela-Bueno, A., Jacoby, J., & Kales, J. D. (1982) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1982.236 · Cited by 62
Self-citation
Cited by
Borrelli, F., & Izzo, A. A. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9146-8 · Cited by 288
Metadata
- Authors
- Kales, A.
- Venue
- Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Publisher
- Wiley
- Published
- 1990-01-02
- Volume
- 10
- Issue
- 1
- Pages
- 1-14
- ISSN
- 0277-0008 (ISSN-L)
- 1875-9114
- OpenAlex
- W1714313445
- Cited by
- 188
- References
- 16
- FWCI
- 3.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quazepam: Hypnotic Efficacy and Side Effects. https://app.cochat.ai/papers/10.1002/j.1875-9114.1990.tb02545.x
- The paper
- Kales, A. (1990). Quazepam: Hypnotic Efficacy and Side Effects. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/j.1875-9114.1990.tb02545.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.